Carlos Rocha Oliveira

Dr. Carlos Rocha Oliveira

Anhembi Morumbi University, School of Medicine, São Paulo-SP, Brazil.
+1
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
CBCláudia Bincoletto
Cláudia Bincoletto
ITIvarne L. S. Tersariol
Ivarne L. S. Tersariol
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
SDSimone Dreher
Simone Dreher
DFDaniela M. Fausto
Daniela M. Fausto
ACAntonio C.F. Caires
Antonio C.F. Caires

1 March 2019 in Journal of Integrative Medicine
Verified
Journal Article
Closed access
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
DSDaniel G. Spindola
Daniel G. Spindola
DGDaniel M. Garcia
Daniel M. Garcia
AEAdolfo Garcia Erustes
Adolfo Garcia Erustes
ABAlexandre Bechara
Alexandre Bechara
CBClaudia Bincoletto
Claudia Bincoletto

1 August 2006 in European Journal of Pharmacology
Verified
Journal Article
Closed access
CBChristiano M.V. Barbosa
Christiano M.V. Barbosa
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
Fabio Dupart NascimentoFabio Dupart Nascimento
Fabio Dupart Nascimento
MSMickaela C.M. Smith
Mickaela C.M. Smith
DFDaniela M. Fausto
Daniela M. Fausto
ACAntonio C.F. Caires
Antonio C.F. Caires

1 July 2008 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
TAT.S. Abondanza
T.S. Abondanza
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
CBC.M.V. Barbosa
C.M.V. Barbosa
FPF.E.G. Pereira
F.E.G. Pereira
RCRodrigo L. O. R. Cunha
Rodrigo L. O. R. Cunha
CBC. Bincoletto
C. Bincoletto

1 August 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
CLCauê S. Lima
Cauê S. Lima
DSDaniel G. Spindola
Daniel G. Spindola
ABAlexandre Bechara
Alexandre Bechara
DGDaniel M. Garcia
Daniel M. Garcia
CPCaroline Palmeira-Dos-Santos
Caroline Palmeira-Dos-Santos
CBClaudia Bincoletto
Claudia Bincoletto

23 November 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
BBBrandão-Rangel Brandão-Rangel
Brandão-Rangel Brandão-Rangel
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
Fabiana Regina da Silva OlímpioFabiana Regina da Silva Olímpio
Fabiana Regina da Silva Olímpio
FAFlavio Aimbire
Flavio Aimbire
JSJosé Roberto Mateus da Silva
José Roberto Mateus da Silva
Rodolfo P VieiraRodolfo P Vieira
Rodolfo P Vieira
Collagen-based products are found in different pharmaceuticals, medicine, food, and cosmetics products for a wide variety of applications. However, its use to prevent or improve the health of skin is growing dizzyingly. Therefore, this study investigated whether collagen peptides could induce fibroblast and keratinocyte proliferation and activation beyond reducing an inflammatory response induced by lipopolysaccharide (LPS). Human skin fibroblasts (CCD-1072Sk) and human keratinocytes (hKT-nh-skp-KT0026) were seeded at a concentration of 5 × 104 cells/mL. LPS (10 ng/mL) and three doses of collagen peptides (2.5 mg/mL, 5 mg/mL, 10 mg/mL) were used. The readout parameters were cell proliferation; expression of inducible nitric oxide synthase (iNOS); expression of pro-collagen-1α by fibroblasts; and secretion of interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor α (TNF-α), transforming growth factor β (TGF-β), and vascular endothelial growth factor (VEGF) by both cell types. The results demonstrated that all doses of collagen supplementation induced increased proliferation of both human fibroblasts (p < 0.01) and human keratinocytes (p < 0.001), while only the dose of 10 mg/mL induced an increased expression of pro-collagen-1α by fibroblasts. Similarly, only the dose of 10 mg/mL reduced LPS-induced iNOS expression in fibroblasts (p < 0.05) and keratinocytes (p < 0.01). In addition, collagen supplementation reduced the LPS-induced IL-1β (p < 0.05), IL-6 (p < 0.001), IL-8 (p < 0.01), and TNF-α (p < 0.05), and increased the TGF-β and VEGF expression in fibroblasts. Furthermore, collagen supplementation reduced the LPS-induced IL-1β (p < 0.01), IL-6 (p < 0.01), IL-8 (p < 0.01), and TNF-α (p < 0.001), and increased the TGF-β (p < 0.05) and VEGF (p < 0.05) expression in keratinocytes. In conclusion, collagen peptides were found to induce fibroblast and keratinocyte proliferation and pro-collagen-1α expression, involving increased expression of TGF-β and VEGF, as well as the suppression of an inflammatory response induced by LPS.